What does Dr. Van Haeringen Polygen do?

Dr. Van Haeringen Polygen is a healthcare practice in Malle. Private Limited, started on 4 November 2002, 1 establishment.

What is the address of Dr. Van Haeringen Polygen?

The registered office of Dr. Van Haeringen Polygen is located at Kasteellaan 7, 2390 Malle.

Is Dr. Van Haeringen Polygen still active?

Yes. According to the CBE (30 October 2026) Dr. Van Haeringen Polygen is active, legal situation “Normale toestand”, started on 4 November 2002.

Is Dr. Van Haeringen Polygen registered on Peppol?

Yes, Dr. Van Haeringen Polygen is registered on the Peppol network with ID 0208:0478715982.

What is the enterprise number of Dr. Van Haeringen Polygen?

The enterprise number of Dr. Van Haeringen Polygen is BE0478715982.

When was Dr. Van Haeringen Polygen founded?

Dr. Van Haeringen Polygen was founded on 4 November 2002.

Who are the directors of Dr. Van Haeringen Polygen?

According to the 2025 annual accounts, the directors of Dr. Van Haeringen Polygen are: Van Haeringen Global BV.

Is Dr. Van Haeringen Polygen a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 November 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Van Haeringen Polygen make in 2025?

Dr. Van Haeringen Polygen recorded a loss after taxes of € 10,895 in financial year 2025.

What is the revenue of Dr. Van Haeringen Polygen?

As a small company, Dr. Van Haeringen Polygen is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 129,545.

Dr. Van Haeringen Polygen (Private Limited) - Malle

Dossier Dr. Van Haeringen Polygen, printed on 30 October 2026 from databakkes.be/en/0478715982/dr-van-haeringen-polygen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

Dr. Van Haeringen Polygen from Malle, company number BE0478715982, closed financial year 2025 with a result of € -10,895 after tax. For that financial year Dr. Van Haeringen Polygen recorded a gross margin of € 129,545 and equity of € 8,744. Compared with financial year 2024, the result moved from € -765 to € -10,895. The company made a loss. The buffer shrank hard: equity is 55 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 7, 2026.

What it is worth Shrank hard

€ 8,744

▼ 55% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -10,895

▼ 1324 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 20,220

▼ 34% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -9,806.

People and assets in 2025

Wage cost

€ 138,904

▲ 23% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

€ 10,000

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 12,122

▲ 28% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 32,364

▼ 7% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 105,151 Gross margin 2022: € 105,151 First fiscal year in the series	€ 113,843 Gross margin 2023: € 113,843 ▲ 8% vs 2022 (€ 105,151) Favourable step	€ 113,978 Gross margin 2024: € 113,978 Unchanged (€ 113,843) Favourable step	€ 129,545 Gross margin 2025: € 129,545 ▲ 14% vs 2024 (€ 113,978) Favourable step	▲ 14%
Profit after taxes	€ 18,773 Profit after taxes 2022: € 18,773 First fiscal year in the series	€ 15,076 Profit after taxes 2023: € 15,076 ▼ 20% vs 2022 (€ 18,773) Unfavourable step	€ -765 Profit after taxes 2024: € -765 ▼ € 15,842 vs 2023 (€ 15,076) Unfavourable step	€ -10,895 Profit after taxes 2025: € -10,895 ▼ € 10,130 vs 2024 (€ -765) Unfavourable step	▼ € 10,130
Equity	€ 20,405 Equity 2022: € 20,405 First fiscal year in the series	€ 20,405 Equity 2023: € 20,405 Unchanged (€ 20,405) Unchanged	€ 19,640 Equity 2024: € 19,640 ▼ 4% vs 2023 (€ 20,405) Unfavourable step	€ 8,744 Equity 2025: € 8,744 ▼ 55% vs 2024 (€ 19,640) Unfavourable step	▼ 55%
Total debts	€ 135,487 Total debts 2022: € 135,487 First fiscal year in the series	€ 66,529 Total debts 2023: € 66,529 ▼ 51% vs 2022 (€ 135,487) Favourable step	€ 44,271 Total debts 2024: € 44,271 ▼ 33% vs 2023 (€ 66,529) Favourable step	€ 54,486 Total debts 2025: € 54,486 ▲ 23% vs 2024 (€ 44,271) Unfavourable step	▲ 23%
Cash	€ 114,245 Cash 2022: € 114,245 First fiscal year in the series	€ 57,289 Cash 2023: € 57,289 ▼ 50% vs 2022 (€ 114,245) Unfavourable step	€ 30,721 Cash 2024: € 30,721 ▼ 46% vs 2023 (€ 57,289) Unfavourable step	€ 20,220 Cash 2025: € 20,220 ▼ 34% vs 2024 (€ 30,721) Unfavourable step	▼ 34%
Retained profit	€ 1,855 Retained profit 2022: € 1,855 First fiscal year in the series	€ 1,855 Retained profit 2023: € 1,855 Unchanged (€ 1,855) Unchanged	€ 1,090 Retained profit 2024: € 1,090 ▼ 41% vs 2023 (€ 1,855) Unfavourable step	€ -9,806 Retained profit 2025: € -9,806 ▼ € 10,895 vs 2024 (€ 1,090) Unfavourable step	▼ € 10,895
Dividend	€ 79,909 Dividend 2022: € 79,909 First fiscal year in the series	€ 15,076 Dividend 2023: € 15,076 ▼ 81% vs 2022 (€ 79,909) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 15,076) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 10,000 Bank debt 2025: € 10,000 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 155,892 Balance sheet total 2022: € 155,892 First fiscal year in the series	€ 86,934 Balance sheet total 2023: € 86,934 ▼ 44% vs 2022 (€ 155,892) Unchanged	€ 63,911 Balance sheet total 2024: € 63,911 ▼ 26% vs 2023 (€ 86,934) Unchanged	€ 63,230 Balance sheet total 2025: € 63,230 ▼ 1% vs 2024 (€ 63,911) Unchanged	▼ 1%

Key figures of Dr. Van Haeringen Polygen, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Van Haeringen Polygen?

What happened at Dr. Van Haeringen Polygen in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 7, 2026 New annual accounts for financial year 2025: loss of € 10,895. filed late Source: NBB ↗
2024 Van Haeringen Global BV became a director. NBB
Feb 11, 2003 New establishment in Malle. KBO
Nov 4, 2002 Start of the company according to the CBE. KBO

In short

From € 18,773 profit in 2022 to € 10,895 loss in 2025.

Paid € 11,732 in corporate taxes since 2022.

Best year ever: 2022, with € 18,773 profit.

Paid out € 94,986 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Van Haeringen Global BV

Dr. Van Haeringen Polygen

Behind Dr. Van Haeringen Polygen is Van Haeringen Global BV.

Directors

According to the 2025 annual accounts

Van Haeringen Global BV

Director · represented by Kris Van Malderen

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Kasteellaan 7

2390 Malle

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0478.715.982

VAT number

BE 0478.715.982

Registered office

Kasteellaan 7, 2390 Malle

Names & denominations

Dr. Van Haeringen Polygen

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

4 November 2002

Peppol

Active · Active since 2 Jan 2026

Activities · NACE

Activiteiten van medische beeldvorming en medische laboratoria

Medische laboratoria

Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Activiteiten van medische laboratoria

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Van Haeringen Polygen

Warning lights

Financials

What happened to Dr. Van Haeringen Polygen?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions